SAN FRANCISCO, March 11 /PRNewswire-FirstCall/ -- VIA Pharmaceuticals (Nasdaq: VIAP), a biotechnology company focused on the development of compounds for the treatment of cardiovascular disease, announced today that Lawrence Cohen PhD, chief executive officer, and James G. Stewart, senior vice president and chief financial officer, will present a company update at the 2008 Cowen and Company 28th Annual Health Care Conference on Tuesday, March 18, 2008 at 1:40 p.m. ET at the Boston Copley Marriott Place Hotel in Boston.
Interested parties may access a live audio webcast of the presentation from the investor section of the VIA website, http://www.viapharmaceuticals.com. A replay of the presentation will be archived on the site for at least one week following the presentation.
About VIA Pharmaceuticals, Inc.
VIA Pharmaceuticals, Inc. is a biotechnology company focused on the development of compounds for the treatment of cardiovascular disease. VIA is building a pipeline of small-molecule drugs that target a significant unmet medical need: reducing inflammation in the blood vessel wall, which is an underlying cause of atherosclerosis and its complications, including heart attack and stroke. The company's lead drug candidate, VIA-2291, is in multiple Phase 2 clinical studies in patients with cardiovascular disease. For more information, visit: http://www.viapharmaceuticals.com.
|SOURCE VIA Pharmaceuticals|
Copyright©2008 PR Newswire.
All rights reserved